Given the high prevalence of APC and ARID2 mutations in other gastrointestinal tumors such as colorectal cancers and hepatocellular carcinomas [21, 25] instead of gastric adenocarcinomas, this finding suggests that gastric adenoma may represent a disease category distinguished from gastric adenocarcinomas. This evidence concerns the gene ARID2 and gastric adenocarcinoma.